Synmosa Biopharma Corp(TW:4114)
NT$27.75-0.10 (-0.36%)
TW:4114
Synmosa Biopharma Corp financials statements
NT$27.75
At close:-0.10 (-0.36%)
Synmosa Biopharma Corp (4114) Financial Statements
Synmosa Biopharma Corp Financial Overview
Synmosa Biopharma Corp's market cap is currently NT$14.97B. The company's EPS TTM is NT$1.58; its P/E ratio is 17.66; and it has a dividend yield of 3.06%. Synmosa Biopharma Corp has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 6.19B | NT$ 5.55B | NT$ 5.14B | NT$ 4.39B | NT$ 3.23B |
| Gross Profit | NT$ 2.54B | NT$ 2.40B | NT$ 2.12B | NT$ 1.83B | NT$ 1.29B |
| Operating Income | NT$ 778.48M | NT$ 739.08M | NT$ 614.74M | NT$ 788.00M | NT$ 207.68M |
| EBITDA | NT$ 1.12B | NT$ 1.06B | NT$ 1.01B | NT$ 1.10B | NT$ 507.92M |
| Net Income | NT$ 821.85M | NT$ 684.68M | NT$ 594.83M | NT$ 799.09M | NT$ 303.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 2.93B | NT$ 1.89B | NT$ 1.65B | NT$ 1.42B | NT$ 993.13M |
| Total Assets | NT$ 13.99B | NT$ 12.30B | NT$ 11.73B | NT$ 11.20B | NT$ 10.32B |
| Total Debt | NT$ 2.52B | NT$ 2.55B | NT$ 2.44B | NT$ 3.37B | NT$ 3.46B |
| Net Debt | NT$ 624.76M | NT$ 1.37B | NT$ 1.52B | NT$ 2.28B | NT$ 2.60B |
| Total Liabilities | NT$ 3.89B | NT$ 3.91B | NT$ 3.63B | NT$ 4.55B | NT$ 4.22B |
| Stockholders' Equity | NT$ 8.76B | NT$ 7.21B | NT$ 6.71B | NT$ 5.31B | NT$ 4.71B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 130.44M | NT$ 510.97M | NT$ 242.16M | NT$ 445.92M | NT$ 312.74M |
| Operating Cash Flow | NT$ 411.57M | NT$ 780.62M | NT$ 511.93M | NT$ 630.25M | NT$ 454.86M |
| Investing Cash Flow | NT$ -663.53M | NT$ -336.80M | NT$ -717.87M | NT$ -69.33M | NT$ 73.33M |
| Financing Cash Flow | NT$ 964.20M | NT$ -187.55M | NT$ 37.24M | NT$ -347.94M | NT$ -297.57M |
Currency in TWD
